Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice.
Department of Family Medicine, Community and Preventive Medicine, and Oncology, University of Rochester, School of Medicine and Dentistry and Wilmot Cancer Center, Rochester, NY.Mayo Clinic Proceedings (Impact Factor: 5.79). 08/2012; 87(8):806; author reply 806-8. DOI: 10.1016/j.mayocp.2012.04.008
- [Show abstract] [Hide abstract]
ABSTRACT: It remains controversial whether it is safe for recovering health care professionals to return to clinical practice after treatment for drug addiction. One specific component of reentry that remains particularly contentious is the use of pharmacotherapeutics, specifically buprenorphine, as opioid substitution therapy for health care professionals who wish to return to clinical work. Because health care professionals are typically engaged in safety-sensitive work with considerable consequences when errors occur, abstinence-based recovery should be recommended until studies demonstrate that it is safe to allow this population to practice while undergoing opioid substitution therapy.Mayo Clinic Proceedings 03/2012; 87(3):260-7. · 5.79 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.